参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/08/10 | 3,410 | 3,410 | 3,380 | 3,395 | +5 | +0.1% | 2,600 |
2012/08/09 | 3,380 | 3,390 | 3,345 | 3,390 | +15 | +0.4% | 9,000 |
2012/08/08 | 3,375 | 3,375 | 3,370 | 3,375 | +10 | +0.3% | 3,600 |
2012/08/07 | 3,265 | 3,365 | 3,265 | 3,365 | +30 | +0.9% | 1,300 |
2012/08/06 | 3,340 | 3,390 | 3,335 | 3,335 | ±0 | ±0% | 3,100 |
2012/08/03 | 3,360 | 3,360 | 3,335 | 3,335 | -25 | -0.7% | 2,800 |
2012/08/02 | 3,310 | 3,385 | 3,310 | 3,360 | +50 | +1.5% | 9,600 |
2012/08/01 | 3,325 | 3,370 | 3,305 | 3,310 | -20 | -0.6% | 3,200 |
2012/07/31 | 3,315 | 3,340 | 3,315 | 3,330 | -35 | -1% | 4,000 |
2012/07/30 | 3,240 | 3,365 | 3,240 | 3,365 | +125 | +3.9% | 5,200 |
2012/07/27 | 3,295 | 3,295 | 3,240 | 3,240 | -20 | -0.6% | 1,300 |
2012/07/26 | 3,290 | 3,290 | 3,245 | 3,260 | -25 | -0.8% | 4,700 |
2012/07/25 | 3,340 | 3,360 | 3,285 | 3,285 | -30 | -0.9% | 3,700 |
2012/07/24 | 3,295 | 3,315 | 3,295 | 3,315 | +30 | +0.9% | 2,200 |
2012/07/23 | 3,255 | 3,315 | 3,255 | 3,285 | ±0 | ±0% | 12,300 |
2012/07/20 | 3,320 | 3,325 | 3,285 | 3,285 | -65 | -1.9% | 2,600 |
2012/07/19 | 3,355 | 3,375 | 3,350 | 3,350 | -5 | -0.1% | 3,800 |
2012/07/18 | 3,360 | 3,360 | 3,335 | 3,355 | +60 | +1.8% | 3,300 |
2012/07/17 | 3,265 | 3,310 | 3,265 | 3,295 | +25 | +0.8% | 700 |
2012/07/13 | 3,245 | 3,295 | 3,245 | 3,270 | - | - | 3,100 |
2012/07/12 | 0 | 0 | 0 | 0 | - | - | 0 |
2012/07/11 | 3,245 | 3,255 | 3,220 | 3,245 | -10 | -0.3% | 2,600 |
2012/07/10 | 3,280 | 3,290 | 3,255 | 3,255 | +15 | +0.5% | 2,000 |
2012/07/09 | 3,135 | 3,250 | 3,135 | 3,240 | +70 | +2.2% | 1,900 |
2012/07/06 | 3,210 | 3,240 | 3,170 | 3,170 | -60 | -1.9% | 3,000 |
2012/07/05 | 3,285 | 3,285 | 3,230 | 3,230 | -80 | -2.4% | 1,000 |
2012/07/04 | 3,310 | 3,310 | 3,310 | 3,310 | +5 | +0.2% | 1,900 |
2012/07/03 | 3,250 | 3,305 | 3,250 | 3,305 | +90 | +2.8% | 4,400 |
2012/07/02 | 3,285 | 3,285 | 3,195 | 3,215 | -45 | -1.4% | 4,300 |
2012/06/29 | 3,210 | 3,265 | 3,210 | 3,260 | +50 | +1.6% | 7,500 |
2012/06/28 | 3,155 | 3,220 | 3,155 | 3,210 | -15 | -0.5% | 1,900 |
2012/06/27 | 3,195 | 3,225 | 3,190 | 3,225 | +65 | +2.1% | 9,900 |
2012/06/26 | 3,120 | 3,195 | 3,120 | 3,160 | +50 | +1.6% | 12,700 |
2012/06/25 | 3,165 | 3,165 | 3,105 | 3,110 | -40 | -1.3% | 2,300 |
2012/06/22 | 3,125 | 3,165 | 3,125 | 3,150 | +35 | +1.1% | 1,500 |
2012/06/21 | 3,100 | 3,115 | 3,100 | 3,115 | +65 | +2.1% | 1,900 |
2012/06/20 | 3,010 | 3,110 | 3,010 | 3,050 | +93 | +3.1% | 2,900 |
2012/06/19 | 2,851 | 2,987 | 2,851 | 2,957 | +63 | +2.2% | 1,200 |
2012/06/18 | 2,940 | 2,960 | 2,893 | 2,894 | +4 | +0.1% | 3,400 |
2012/06/15 | 2,898 | 2,898 | 2,879 | 2,890 | +10 | +0.3% | 2,600 |
2012/06/14 | 2,831 | 2,880 | 2,831 | 2,880 | +15 | +0.5% | 1,800 |
2012/06/13 | 2,859 | 2,865 | 2,854 | 2,865 | ±0 | ±0% | 800 |
2012/06/12 | 2,875 | 2,875 | 2,862 | 2,865 | -10 | -0.3% | 8,700 |
2012/06/11 | 2,835 | 2,898 | 2,835 | 2,875 | -10 | -0.3% | 6,100 |
2012/06/08 | 2,949 | 2,949 | 2,850 | 2,885 | -51 | -1.7% | 59,800 |
2012/06/07 | 2,843 | 2,936 | 2,843 | 2,936 | +83 | +2.9% | 5,400 |
2012/06/06 | 2,857 | 2,857 | 2,853 | 2,853 | -1 | ±0% | 5,200 |
2012/06/05 | 2,858 | 2,858 | 2,818 | 2,854 | +26 | +0.9% | 700 |
2012/06/04 | 2,799 | 2,828 | 2,790 | 2,828 | -12 | -0.4% | 3,900 |
2012/06/01 | 2,821 | 2,844 | 2,821 | 2,840 | +20 | +0.7% | 6,100 |
3101~
3150
件表示中 / 3682件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 138,400円 | 0.0% | +50.6% | 2.60% | 14.53倍 | 1.64倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 171,200円 | -3.5% | -50.2% | 4.67% | 13.86倍 | 1.03倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 231,900円 | +18.2% | +4.2% | 1.55% | 16.27倍 | 2.07倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 445,000円 | +5.8% | +1.2% | 2.70% | 14.76倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 428,100円 | +20.9% | +87.3% | 3.18% | 9.56倍 | 1.10倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム